Feasibility, Acceptability, and Preliminary Outcomes of an Integrated Telemedicine Intervention Combining Naltrexone and Cognitive Behavioral Therapy for Alcohol Use Disorder.

Glasner, Suzette; Webb, Jamie; Michero, Darcy; Motschman, Courtney; Monico, Laura; Ang, Alfonso; Pielsticker, Peyton

Glasner, Suzette; Webb, Jamie; Michero, Darcy; Motschman, Courtney; Monico, Laura; Ang, Alfonso; Pielsticker, Peyton.

Afiliação

Glasner S; Department of Clinical Affairs, Digital Therapeutics, Inc., San Francisco, California, USA.
Webb J; Department of Psychiatry & Biobehavioral Sciences, UCLA Integrated Substance Abuse Programs, Los Angeles, California, USA.
Michero D; Department of Clinical Affairs, Digital Therapeutics, Inc., San Francisco, California, USA.
Motschman C; Department of Clinical Affairs, Digital Therapeutics, Inc., San Francisco, California, USA.
Monico L; Department of Psychological Sciences, University of Missouri, Columbia, Missouri, USA.
Ang A; Friends Research Institute, Baltimore, Maryland, USA.
Pielsticker P; Department of Clinical Affairs, Digital Therapeutics, Inc., San Francisco, California, USA.

Telemed Rep ; 3(1): 184-190, 2022.

Article em En | MEDLINE | ID: mdl-36479135